Logo

Bruker s Organic Q4 Revenues Dip Slightly Though Loss Turns to Profit

Feb 23, 2006

NEW YORK, Feb. 23 (GenomeWeb News) - Bruker BioSciences yesterday reported fourth quarter 2005 revenues of $80.6 million, down from $85.6 million in the fourth quarter of 2004.

 

Revenues increased by 1 percent when adjusted for foreign currency effects, the company said.

 

Bruker reported net income of $1.9 million for the period ended Dec. 31, compared to a loss of $900,000 in the year-ago period.

 

R&D expenses dropped to $9.4 million in the current quarter, versus $12.1 million in the similar quarter last year.

 

The company had around $99.7 million in cash and short-term investments as of Dec. 31.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.